Tango Therapeutics, Inc.(TNGX)

$24.92—Stale · unknown old

WatchlistAsk SA Chart

Tango Therapeutics, Inc.(TNGX)

NASDAQ • Last print unknown ago

$24.92—Stale · unknown old

WatchlistAsk SA Chart Studio

TNGX(TNGX)

TNGX

Next report

Nov 3 2026in 37 days

EPS estimate

($0.34)

Revenue estimate

$3M

EPS beats

6 of last 12

EPS surprise

Each report against the estimate that stood when it landed.

Nov 8 2023Aug 10 2026

Reported	EPS est	EPS actual	Surprise	Revenue est	Revenue actual	Surprise
Aug 10 2026	($0.32)	($0.37)	-16.6%	$2M	—	—
May 13 2026	($0.31)	($0.32)	-2.0%	$578091	—	—
Mar 5 2026	($0.31)	($0.29)	+6.5%	$500400	—	—
Nov 4 2025	$0.01	$0.13	+1200.0%	$556000	$54M	+9578.2%
Aug 5 2025	($0.35)	($0.35)	+0.0%	$6M	$3M	-50.3%
May 12 2025	($0.34)	($0.36)	-5.9%	$6M	$5M	-15.2%
Feb 27 2025	($0.32)	($0.35)	-9.4%	$8M	$4M	-48.6%
Nov 6 2024	($0.34)	($0.27)	+20.6%	$8M	$12M	+44.8%
Aug 7 2024	($0.34)	($0.24)	+29.4%	$7M	$20M	+167.9%
May 8 2024	($0.31)	($0.35)	-12.9%	$7M	$6M	-3.0%
Mar 18 2024	($0.28)	($0.32)	-14.3%	$8M	$5M	-34.1%
Nov 8 2023	($0.34)	($0.23)	+32.4%	$9M	$11M	+24.5%

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-43.22%

EPS—

FY2028

Rev+1241.59%

EPS—

FY2029

Rev+556.79%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$6M	$3M	$46M	$303M	$863M
Low	$6M	$3M	$46M	$303M	$863M
High	$6M	$3M	$46M	$303M	$863M
EBITDA Avg	$-165M	$-215M	$-230M	$-143M	$208M
Low	$-179M	$-252M	$-305M	$-143M	$208M
High	$-151M	$-179M	$-156M	$-143M	$208M
EBIT Avg	$-167M	$-217M	$-232M	$-149M	$188M
Low	$-181M	$-254M	$-307M	$-149M	$188M
High	$-153M	$-180M	$-158M	$-149M	$188M
Net Income Avg	$-167M	$-217M	$-232M	$-149M	$148M
Low	$-181M	$-254M	$-307M	$-149M	$148M
High	$-153M	$-180M	$-158M	$-149M	$148M
EPS Avg	$-1.42	$-1.70	$-1.96	$-1.29	$1.28
Low	$-1.56	$-2.18	$-2.64	$-1.29	$1.28
High	$-1.31	$-1.55	$-1.36	$-1.29	$1.28
Analysts (Rev / EPS)	7 / 10	7 / 9	10 / 9	5 / 3	5 / 3

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$3M	$636,727	$1M	$1M	$1M	$1M
Low	$3M	$636,727	$1M	$1M	$1M	$1M
High	$3M	$636,727	$1M	$1M	$1M	$1M
EBITDA Avg	$-53M	$-57M	$-56M	$-59M	$-63M	$-66M
Low	$-63M	$-69M	$-56M	$-59M	$-63M	$-66M
High	$-46M	$-49M	$-56M	$-59M	$-63M	$-66M
EBIT Avg	$-53M	$-57M	$-57M	$-60M	$-64M	$-67M
Low	$-64M	$-70M	$-57M	$-60M	$-64M	$-67M
High	$-47M	$-49M	$-57M	$-60M	$-64M	$-67M
Net Income Avg	$-53M	$-57M	$-57M	$-60M	$-64M	$-67M
Low	$-64M	$-70M	$-57M	$-60M	$-64M	$-67M
High	$-47M	$-49M	$-57M	$-60M	$-64M	$-67M
EPS Avg	$-0.35	$-0.38	$-0.38	$-0.40	$-0.43	$-0.44
Low	$-0.43	$-0.46	$-0.38	$-0.40	$-0.43	$-0.44
High	$-0.31	$-0.33	$-0.38	$-0.40	$-0.43	$-0.44
Analysts (Rev / EPS)	7 / 9	10 / 9	5 / 6	5 / 3	8 / 3	5 / 6

Earnings Call Transcripts

No earnings transcripts available for TNGX

Transcripts may not be available for all companies

Explore More

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Strategy Focus List

Continuous multi-factor scoring & catalyst forensics

Market Movers

Today's biggest gainers and losers